6bgk Citations

Modifications to a common phosphorylation network provide individualized control in caspases.

J Biol Chem 293 5447-5461 (2018)
Related entries: 6bdv, 6bfj, 6bfk, 6bfl, 6bfo, 6bg0, 6bg1, 6bg4, 6bgq, 6bgr, 6bgs, 6bh9, 6bha

Cited: 17 times
EuropePMC logo PMID: 29414778

Abstract

Caspase-3 activation and function have been well-defined during programmed cell death, but caspase activity, at low levels, is also required for developmental processes such as lymphoid proliferation and erythroid differentiation. Post-translational modification of caspase-3 is one method used by cells to fine-tune activity below the threshold required for apoptosis, but the allosteric mechanism that reduces activity is unknown. Phosphorylation of caspase-3 at a conserved allosteric site by p38-MAPK (mitogen-activated protein kinase) promotes survival in human neutrophils, and the modification of the loop is thought to be a key regulator in many developmental processes. We utilized phylogenetic, structural, and biophysical studies to define the interaction networks that facilitate the allosteric mechanism in caspase-3. We show that, within the modified loop, Ser150 evolved with the apoptotic caspases, whereas Thr152 is a more recent evolutionary event in mammalian caspase-3. Substitutions at Ser150 result in a pH-dependent decrease in dimer stability, and localized changes in the modified loop propagate to the active site of the same protomer through a connecting surface helix. Likewise, a cluster of hydrophobic amino acids connects the conserved loop to the active site of the second protomer. The presence of Thr152 in the conserved loop introduces a "kill switch" in mammalian caspase-3, whereas the more ancient Ser150 reduces without abolishing enzyme activity. These data reveal how evolutionary changes in a conserved allosteric site result in a common pathway for lowering activity during development or a more recent cluster-specific switch to abolish activity.

Articles - 6bgk mentioned but not cited (1)

  1. Modifications to a common phosphorylation network provide individualized control in caspases. Thomas ME, Grinshpon R, Swartz P, Clark AC. J Biol Chem 293 5447-5461 (2018)


Reviews citing this publication (3)

  1. Evolution of an allosteric "off switch" in apoptotic caspases. Herr AB. J. Biol. Chem. 293 5462-5463 (2018)
  2. How does caspases regulation play role in cell decisions? apoptosis and beyond. Ghorbani N, Yaghubi R, Davoodi J, Pahlavan S. Mol Cell Biochem (2023)
  3. Nonapoptotic caspases in neural development and in anesthesia-induced neurotoxicity. Sarić N, Hashimoto-Torii K, Jevtović-Todorović V, Ishibashi N. Trends Neurosci 45 446-458 (2022)

Articles citing this publication (13)

  1. Caspase-3 Cleaves Extracellular Vesicle Proteins During Auditory Brainstem Development. Weghorst F, Mirzakhanyan Y, Samimi K, Dhillon M, Barzik M, Cunningham LL, Gershon PD, Cramer KS. Front Cell Neurosci 14 573345 (2020)
  2. Requirement for Serine-384 in Caspase-2 processing and activity. Zamaraev AV, Volik PI, Nilov DK, Turkina MV, Egorshina AY, Gorbunova AS, Iarovenko SI, Zhivotovsky B, Kopeina GS. Cell Death Dis 11 825 (2020)
  3. The CaspBase: a curated database for evolutionary biochemical studies of caspase functional divergence and ancestral sequence inference. Grinshpon RD, Williford A, Titus-McQuillan J, Clay Clark A. Protein Sci. 27 1857-1870 (2018)
  4. Caspases from scleractinian coral show unique regulatory features. Shrestha S, Tung J, Grinshpon RD, Swartz P, Hamilton PT, Dimos B, Mydlarz L, Clark AC. J Biol Chem 295 14578-14591 (2020)
  5. Conserved folding landscape of monomeric initiator caspases. Nag M, Clark AC. J Biol Chem 299 103075 (2023)
  6. Design, Synthesis, and Anticancer Screening for Repurposed Pyrazolo[3,4-d]pyrimidine Derivatives on Four Mammalian Cancer Cell Lines. Othman EM, Bekhit AA, Anany MA, Dandekar T, Ragab HM, Wahid A. Molecules 26 2961 (2021)
  7. Discovering Potential Anti-Oral Squamous Cell Carcinoma Mechanisms from Kochiae Fructus Using Network-Based Pharmacology Analysis and Experimental Validation. Kim YS, Lee JC, Lee M, Oh HJ, An WG, Sung ES. Life (Basel) 13 1300 (2023)
  8. Efficient synthesis of meso-substituted porphyrins and molecular docking as potential new antioxidant and cytotoxicity agents. Abu-Melha S. Arch. Pharm. (Weinheim) 352 e1800221 (2019)
  9. Evolution of the folding landscape of effector caspases. Shrestha S, Clark AC. J Biol Chem 297 101249 (2021)
  10. Identification of Allosteric Inhibitors against Active Caspase-6. Tubeleviciute-Aydin A, Beautrait A, Lynham J, Sharma G, Gorelik A, Deny LJ, Soya N, Lukacs GL, Nagar B, Marinier A, LeBlanc AC. Sci Rep 9 5504 (2019)
  11. Non-Apoptotic Caspase Activity Preferentially Targets a Novel Consensus Sequence Associated With Cytoskeletal Proteins in the Developing Auditory Brainstem. Weghorst F, Mirzakhanyan Y, Hernandez KL, Gershon PD, Cramer KS. Front Cell Dev Biol 10 844844 (2022)
  12. Remodeling hydrogen bond interactions results in relaxed specificity of Caspase-3. Yao L, Swartz P, Hamilton PT, Clark AC. Biosci Rep 41 (2021)
  13. Resurrection of ancestral effector caspases identifies novel networks for evolution of substrate specificity. Grinshpon RD, Shrestha S, Titus-McQuillan J, Hamilton PT, Swartz PD, Clark AC. Biochem. J. 476 3475-3492 (2019)